Candidate placental biomarkers for intrauterine alcohol exposure

Pradeep K Shukla1, Laura J Sittig, Timothy M Ullmann

  • 1Department of Psychiatry and Behavioral Sciences, The Asher Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Insights

Identifying placental biomarkers for fetal alcohol spectrum disorder (FASD) is crucial for early diagnosis. This study found specific changes in placental Dio3, TRα1, and GR levels in an animal model, suggesting their potential as biomarkers for prenatal alcohol exposure.

Area of Science:

  • Reproductive biology
  • Developmental toxicology
  • Biomarker discovery

Background:

  • Fetal alcohol spectrum disorder (FASD) is a primary cause of nongenetic intellectual disability and neurodevelopmental issues.
  • Early FASD diagnosis significantly improves outcomes for affected individuals and families.
  • This study utilizes an animal model that mirrors human FASD to identify placental biomarkers.

Purpose of the Study:

  • To identify candidate placental biomarkers for early detection of fetal alcohol spectrum disorder (FASD).
  • To investigate the expression of specific genes and proteins in the placenta following prenatal ethanol exposure.

Main Methods:

  • Pregnant Sprague-Dawley rats were divided into ethanol (E), pair-fed (PF), and control (C) diet groups.
  • Placentae were collected at gestational day 21 for analysis.
  • Western blotting and RT-PCR measured placental levels of iodothyronine deiodinase III (Dio3), thyroid hormone receptor α1 (TRα1), glucocorticoid receptor (GR), Igf-2, Phlda2, and Cdkn1c.

Main Results:

  • Ethanol-exposed dams exhibited increased placental Dio3 and decreased TRα1 and GR protein levels compared to controls.
  • Placental mRNA levels of intrauterine growth restriction markers Igf-2, Phlda2, and Cdkn1c were altered in both PF and E groups.
  • A distinct pattern of altered Dio3, TRα1, and GR was observed in the ethanol group.

Conclusions:

  • A specific pattern of increased Dio3 and decreased TRα1 and GR protein levels in the placenta is proposed as a selective biomarker for intrauterine alcohol exposure.
  • These placental changes may aid in the early diagnosis of fetal alcohol spectrum disorder.
  • The findings provide a foundation for developing non-invasive diagnostic tools for prenatal alcohol exposure.
Abstract